 |
Autologous DNP-conjugated tumor vaccine |
|---|---|
| Trade Name | M-Vax |
| Orphan Indication | Metastatic Melanoma |
| USA Market Approval | USA |
| USA Designation Date | 1999-02-23 00:00:00 |
| Sponsor | Avax Technologies, Inc.;9200 Indian Creek Parkway, Building 9, Suite 200;Overland Park, Kansas, 66210 |
